Higher Cortical Function Deficits After Stroke: An Analysis of 1,000 Patients from a Dedicated Cognitive Stroke Registry

Abstract

Objective: Despite spectacular success of animal model neuroprotective therapy in stroke, these agents have been uniformly unsuccessful in humans. One possible ex planation is the crudity of cerebral measurement by insensitive of stroke scales com prising scant or absent higher cortical-function parameters and the heterogeneity of stroke syndromes and etiology. We sought to determine the frequency and extent of cognitive disorders after stroke and their relation to stroke risk factors, syndromes, le sion site, and etiology. Methods: We used hospital-based consecutive stroke cases. A tiered, hierarchic, cerebrovascular investigative protocol and a battery of predefined, validated bedside higher cortical function deficit (HCFD) tests with comparison to neuropsychological. Quantification according to the World Health Organization lev els of disease model was achieved by a clinical neurologic deficit scale, etiologic scale, and disability scale. Results: Stroke deficit, disability and etiology: In patients evaluated (n = 1,000), the admission Canadian Neurological Scale deficit grading was mild, 11.5-9.5 (n = 696); moderate, 9.5-5.5 (n = 204); and severe, 5.0-0 (n = 86); with correlation to Rankin scale of independent (n = 467), mild disability (n = 345) and severe disability (n = 174) with moderate agreement (kappa = 0.54) between the two measurements. The etiologic subtypes included large-vessel atherothrombosis (n = 264), small-vessel atherothrombosis (n = 262), cardioembolic (n = 122), other (dis section, vasculitis, prothrombotic states; n = 253), and unknown (n = 99). Cognitive Data: 1. One or more higher cortical function abnormalities was detected in 607 (63.5%) of 955 nondrowsy patients. The most numerous categories were aphasias (25.2%), apraxias (14.5%), amnesias (11.6%), and frontal network syndromes (9.2%), with the other categories less frequent (3%). Cognitive impairment occurred without elementary neurologic deficits (motor, sensory, or visual impairment) in 137 (22.5%) of 608. The cardloembolic, other, and unknown stroke mechanistic groups differed sig nificantly from the other groups in terms of HCFD (p = 0.01) frequency. HCFD did not differ between younger (younger than 49 years) and older patients (p = 0.194). 3. Univariate and multivariate analyses of risk factors and likelihood of developing an HCFD revealed increasing age, black race, being overweight, and recent infection to be independent variables (p = 0.05). 4. In 76 patients, neuropsychological testing was performed and comparison with the HCFD test revealed a sensitivity of 80.2% (CI, 72-88%) and specificity of 100%. Conclusions: 1. Cognitive impairment is pres ent in the majority of all types of stroke. 2. Cognitive impairment may be the sole pres entation of stroke, unaccompanied by long-tract signs. 3. Stroke etiologic subtype dif fered significantly among the subgroups, but in comparison of young versus older patients, no significant differences in HCFD frequency were recorded. 4. Risk factors for developing cognitive impairment in the indigenous stroke population included increasing age, black race, overweight body habitus, and recent infection. Key Words: Stroke—Cognitive deficit—Higher cortical function.

References

Mohr JP

Thomas Willis Lecture

Cerebrovasc Dis 1999 ;9(suppl 3).45-50

Fmlayson Maj.

Neuropsychological assessment and treatment of stroke patients

Stroke 1990,21(suppl II) 1114-5

Mohr JP , Caplan LR , Melski JW , et al The Harvard Cooperative Stroke Registry a prospective registry Neurology 1978;28.754-62

Bogousslavsky J. , Van Melle G. , Regli F.

The Lausanne Stroke Registry analysis of 1000 consecutive patients with first stroke

Stroke 1988,19.1083-92.

Kannel WB , Dawber TR , Cohen ME , et al Vascular diseases of the brain epidemiologic aspects the Framingham Study Am J Public Health 1965;55-1355-66

Matsumoto N. , Whisnant JP , Kurland LT , et al Natural history of stroke in Rochester Mmnesota, 1955 through 1969 Stroke 1973;4 20-9

Zupping R. , Roose M.

Epidemiology of cerebrovascular disease in Tartu, Estonia, USSR, 1970 through 1973

Stroke 1976,7.187-90.

Chambers BR , Donnan GA , Bladm PF Patterns of stroke an analysis of the first 700 consecutive admissions to the Austm Hospital Stroke Unit. Aust N Z J Med 1983,13.57-64.

Sandercock et al. The Oxfordshire Community Stroke Project: incidence of stroke in Oxfordshire first year's experience of a commumty stroke register. Br Med J 1983,287 713-7.

10.

Mohr JP

Stroke data banks

Stroke 1986;17:171-2

11.

Foulkes MA , Wolf PA , Price TR , et al. The Stroke data bank design, methods and baseline characteristics Stroke 1988;19.547-54. 12 Brust JC , Shafer SQ , Richter RW , et al Aphasia in acute stroke Stroke 1976;7:167-74.

12.

Bramm M, Gugging M, Foulkes MA, eds. Stroke data banks challenges for research. Neuroepidemiology 1994;13.250-346.

13.

Hennques IL , Bogousslavsky J Value of stroke data banks for the analysis of clinical syndromes. Neuroepidemiology 1994;13.296-300.

14.

Bramm M. Overview of stroke data banks. Neuroepidemiology 1994;13-250-8.

15.

Tatemichi TK , Desmond DW , Stern Y. , et al Cognitive impairment after stroke frequency, patterns and relationship to functional abilities J Neurol Neurosurg Psychiatry 1994,57.202-7.

16.

Andersen G. , Vestergaard K. , Oestergaard Rils J. , et al. Intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis 1996,6 363-9

17.

Eslmger PJ , Damasio AR Age and type of aphasia in patients in stroke. J Neurol Neurosurg Psychiatry 1981;44.377-81

18.

Kertesz A. , Sheppard A. The epidemiology of aphasic and cognitive impairment in stroke. Brain 1981,104.117-28

19.

Scarpa M. , Colombo A. , Sorgoto P. , et al. The incidence of aphasia and global aphasia in left brain damaged patients. Cortex 1987,23.331-6.

20.

Wade DT , Langton Hewer R. , David RM , et al. Aphasia after stroke natural history and associated deficits . J Neurol Neurosurg Psychiatry 1986;49 11-6

21.

Carter LT , Caruso JL , Languirand M. , et al. Cognitive skill remediation in stroke and non-stroke elderly . Clin Neuropsychol 1980,2 109-13.

22.

Carter LT , Howard BE , O'Neil WA Effectiveness of cognitive skill remediation in acute stroke patients . Am J Occup Ther 1983;37: 320-6

23.

Wilson B.

Success and failure in memory training following a cerebral vascular accident

Cortex 1982;18:581-94

24.

Hajek VE , Rutman DL , Sher H. Brief assessment of cognitive impairment in patients with stroke. Arch Phys Med Rehabil 1989;70. 114-7

25.

Wade DT , Skilbeck C. , Langton Hewer R. Selected cognitive losses after stroke. frequency, recovery and prognostic importance. Int Disabil Stud 1989,11.34-9.

26.

Egelko S. , Simon D. , Riley E. , et al. First year after stroke tracking cognitive and affective deficits . Arch Phys Med Rehabil 1989;70 297-302.

27.

Lincoln NB , Gamlen R. , Thomason H. Behavioural mapping of patients on a stroke unit. Int Disabil Stud 1989,11 149-54.

28.

de Koning, I. , van Kooten F. , Dippel Dwj , et al. The CAMCOG a useful screening instrument for dementia m stroke patients Stroke 1998 ,29:2080-6

29.

Freeman R. , Bear D. , Greenberg MS Behavioural disturbances in cerebrovascular disease In. Vinken PJ , Bruyn GW , Klawans HL , eds. Handbook of clinical neurology New York Elsevier Science Publishers , 1989 55, 137-50.

30.

Furlan AJ

Unexplained acute changes m behaviour when to think of stroke

Postgrad Med 1988;84 137-46.

31.

Mesulam M-M.

Large scale neurocognitive networks and distributed processing for attention, language and memory

Ann Neurol 1990;28.597-613

32.

Benson DF , Geshwind N. Aphasia and related disorders. a clinical approach. In: Mesulam M-M , ed Principles of behavioral neurology Philadelphia FA Davis, 1985.193-238.

33.

Devmsky O. Behavioural neurology 100 maxims. London Edward Arnold, 1992

34.

Wahlgren NG , Thoren M. Neuroprotective therapy In. Fisher M , Bogousslavsky J , eds. Current review of cerebrovascular disease. Oxford Butterworths, 1998.173-83.

35.

Buchan AM Do NMDA antagonists protect against cerebral ischemia. are clinical trials warranted? Cerebrovasc Bram Metabol Rev 1990 ;2 1-26.

36.

Coté R. , Battista RN , Wolfson C. , et al. The Canadian Neurological Scale. validation and reliability assessment. Neurology 1989,39.638-43

37.

Bamford J. , Sandercock P. , Dennis M. , et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991 ;337:1521-6

38.

Rankin J. Cerebral vascular accidents in patients over the age of 60. prognosis. Scottish Med J 1957,2:200-15

39.

Adams HP , Bendixen BH , Kappelle LJ , et al Classification of subtype of acute ischaemic stroke Stroke 1993;24 35-41

40.

Benton AL The prefrontal region: its early history. In. Levm HS , Eisenberg HM , Benton AL , eds. Frontal lobe function and dysfunction New York. Oxford University Press, 1991.3-32

41.

Fuster JM The prefrontal cortex Philadelphia. Lippincott-Raven, 1997.

42.

Cummings JL

Frontal-subcortical circuits and human behavior

Arch Neurol 1993,50 873-80

43.

Damasio AR The frontal lobes. In Heilman KM , Valenstem E , eds. Clinical neuropsychology New York. Oxford University Press , 1985:339-75

44.

Mesulam M-M. Large scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 1990,28.597-613.

45.

Mesulam MM Frontal cortex and behaviour. Ann Neurol 1986 ;19 320-5

46.

Rosman K. The epidemiology of stroke m an urban black population. Stroke 1986;17:667-9